ProCE Banner Activity

How I Use Brentuximab Vedotin Plus CHP in the Clinic for My Patients With PTCL

Clinical Thought
Consider an improved treatment option for your patients with PTCL with these expert recommendations on the use of brentuximab vedotin with CHP in PTCL based on ECHELON 2 study results.

Released: February 27, 2019

Expiration: February 26, 2020

No longer available for credit.

Share

Faculty

Steven M. Horwitz

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Seagen

Faculty Disclosure

Primary Author

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York